Phage Display Isolation of Antibodies against Antigenically Conserved Membrane Pr
Phage Display Isolation of Antibodies against Antigenically Conserved Membrane Pr
批准号:
8309899
负责人:
Benjamin Jacob Doranz
金额:
$21.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-08-01 至 2014-01-31
关键词:
AbbreviationsAdjuvantAntibodiesAntigensAvidityBacteriophagesBindingBiomedical ResearchCellsCellular MembraneDetectionDetergentsDevelopmentDiagnosticDrug Delivery SystemsEnvironmentEpitopesG-Protein-Coupled ReceptorsImmobilizationImmunoglobulin GIntegral Membrane ProteinIon ChannelLibrariesLicensingLipid BilayersLipidsMarketingMembraneMembrane ProteinsMethodsMolecular ConformationMonoclonal AntibodiesPathway interactionsPhage DisplayPreparationProtocols documentationReagentResearchRoleSignal TransductionSourceSpecificityStructureTechnologyTestingTimeLineVirus-like particlecell typehuman PHEMX proteinhuman diseaseimmunogenicityimprovednew technologyreceptorreceptor densityreceptor functiontherapeutic development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We propose to use a novel technology, the Lipoparticle, to capture and concentrate structurally intact membrane proteins in a format amenable to phage panning for MAb isolation. The use of Lipoparticles to pan phage display libraries represents a valuable approach for obtaining antibodies against conserved membrane protein antigens because 1) Lipoparticles contain high concentrations of conformationally-intact target receptors, 2) target receptors within Lipoparticles are not exposed to adjuvants or biologically destructive environments so remain structurally intact, and 3) target receptors with high sequence conservation across species can be used as targets.
PUBLIC HEALTH RELEVANCE: This proposal will result in monoclonal antibodies against important membrane protein targets for therapeutic development, diagnostics, and biomedical research. Lipoparticles optimized as panning reagents will be developed as a commercial product, and Lipoparticle-derived MAbs against biomedically important membrane protein targets will be licensed for therapeutic development or diagnostic use, or enter the commercial market as research reagents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identifying Regulators of Cellular Aging that can Prevent Alzheimer's Disease
-
批准号:10624244
-
项目类别:
-
资助金额:$8.9万
-
财政年份:2022
-
负责人:Benjamin Jacob Doranz
-
依托单位:
Identifying Regulators of Cellular Aging that can Prevent Alzheimer's Disease
-
批准号:10383454
-
项目类别:
-
资助金额:$35.86万
-
财政年份:2022
-
负责人:Benjamin Jacob Doranz
-
依托单位:
Identifying New Immunomodulatory Targets for Alzheimers and Other Neurodegenerative Diseases
-
批准号:9766179
-
项目类别:
-
资助金额:$20.38万
-
财政年份:2018
-
负责人:Benjamin Jacob Doranz
-
依托单位:
Development of CB1 Monoclonal Antibodies for Treating NASH
-
批准号:9918931
-
项目类别:
-
资助金额:$33.95万
-
财政年份:2018
-
负责人:Benjamin Jacob Doranz
-
依托单位:
Next Generation Specificity Screening for Biotherapeutics using an Extracellular Proteome Array
-
批准号:10206171
-
项目类别:
-
资助金额:$50.24万
-
财政年份:2015
-
负责人:Benjamin Jacob Doranz
-
依托单位:
Next Generation Specificity Screening for Biotherapeutics using an Extracellular Proteome Array
-
批准号:10077411
-
项目类别:
-
资助金额:$93.43万
-
财政年份:2015
-
负责人:Benjamin Jacob Doranz
-
依托单位:
Next Generation Specificity Screening for Biotherapeutics using an Extracellular Proteome Array
-
批准号:10438827
-
项目类别:
-
资助金额:$20.4万
-
财政年份:2015
-
负责人:Benjamin Jacob Doranz
-
依托单位:
High-throughput Identification of Membrane Protein MAbs
-
批准号:8831071
-
项目类别:
-
资助金额:$22.48万
-
财政年份:2015
-
负责人:Benjamin Jacob Doranz
-
依托单位:
Engineering Stable, Soluble, and Trimeric HIV gp140 by Paired Cys Scanning
-
批准号:8404028
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2012
-
负责人:Benjamin Jacob Doranz
-
依托单位:
Engineering Stable, Soluble, and Trimeric HIV gp140 by Paired Cys Scanning
-
批准号:8507144
-
项目类别:
-
资助金额:$24.63万
-
财政年份:2012
-
负责人:Benjamin Jacob Doranz
-
依托单位:
High-throughput Epitope Mapping of Anti-Viral Antibodies
-
批准号:8209413
-
项目类别:
-
资助金额:$24.24万
-
财政年份:2011
-
负责人:Benjamin Jacob Doranz
-
依托单位:
Identification and Development of Novel Influenza M2 Inhibitors
-
批准号:7455439
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Benjamin Jacob Doranz
-
依托单位:
A Tool for Modeling the Structure-Activity of Chemokine Receptors and Other GPCRs
-
批准号:7935070
-
项目类别:
-
资助金额:$17.18万
-
财政年份:2009
-
负责人:Benjamin Jacob Doranz
-
依托单位:
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses
-
批准号:8534623
-
项目类别:
-
资助金额:$160.17万
-
财政年份:2009
-
负责人:Benjamin Jacob Doranz
-
依托单位:
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses
-
批准号:8320838
-
项目类别:
-
资助金额:$182.37万
-
财政年份:2009
-
负责人:Benjamin Jacob Doranz
-
依托单位:
B Cell Epitope Discovery: Dengue, Hepatitis C, Ebola, and Chikungunya viruses
-
批准号:8099181
-
项目类别:
-
资助金额:$174.23万
-
财政年份:2009
-
负责人:Benjamin Jacob Doranz
-
依托单位:
Identification of Novel Influenza Inhibitors
-
批准号:7535123
-
项目类别:
-
资助金额:$32.53万
-
财政年份:2008
-
负责人:Benjamin Jacob Doranz
-
依托单位:
Identification of Novel Influenza Inhibitors
-
批准号:7633252
-
项目类别:
-
资助金额:$27.39万
-
财政年份:2008
-
负责人:Benjamin Jacob Doranz
-
依托单位:
Ion Channel Assay for Identifying Influenza Therapeutics
-
批准号:7153178
-
项目类别:
-
资助金额:$84.51万
-
财政年份:2006
-
负责人:Benjamin Jacob Doranz
-
依托单位:
A Tool for Modeling the Structure-Activity of Chemokine Receptors and Other GPCRs
-
批准号:7272490
-
项目类别:
-
资助金额:$77.54万
-
财政年份:2006
-
负责人:Benjamin Jacob Doranz
-
依托单位:
海外基金